Navigation Links
The ADC does not reflect cytotoxic edema on the uninjured side after TBI
Date:7/15/2014

It is currently difficult to treat traumatic brain injury (TBI) in the clinic. There are abundant neural network connections and humoral regulation mechanisms between the cerebral hemispheres. Brain tissue on the uninjured side after TBI may also undergo abnormal changes, but these changes remain poorly understood. Hong Lu and her team, Affiliated Haikou Hospital, Xiangya School of Medicine, Central South University, in China performed a study to investigate whether apparent diffusion coefficient (ADC) measurements can reflect cytotoxic edema on the uninjured side using diffusion tensor imaging. They found that, on the injured side, vasogenic edema followed by intracellular edema appeared; on the uninjured side, the pathological changes occur later, cytotoxic edema followed by vasogenic edema was visible, but vasogenic edema tended to decrease with time. These results indicate that ADC values can accurately reflect the changes on the injured side, but do not reflect the changes on the uninjured side, giving a false-negative result. Related results were published in Neural Regeneration Research (Vol. 9, No. 9, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. New research finds that cell phones reflect our personal microbiome
2. Natures chemical diversity reflected in Swedish lakes
3. Name of new weakly electric fish species reflects hope for peace in Central Africa
4. Seafood menus from Hawaii reflect long-term ocean changes
5. Alpine lakes reflect climate change
6. Reflections on chevaline
7. Nasal mucosal inhalation of AD vaccine attenuates Aβ1-42-induced cytotoxicity
8. MDC and FMP researchers identify edema inhibitor
9. Step forward in research into new treatments for brain edema
10. Dental pulp stem cells promote the survival and regeneration of retinal cells after injury
11. Fruit fly immunity fails with fungus after (space)flight
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The ADC does not reflect cytotoxic edema on the uninjured side after TBI
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: